Our data are consistent with a recent study that unbiasedly identified Efemp1 coupled with NT-proBNP in patients with acute MI was a strong predictor of secondary outcomes MACE and HF (area-under-the-curve of 0.8)26. This evidence concerns the gene EFEMP1 and hydrops fetalis.